Call Now

Post Market Surveillance Report (PMSR) Services

Cert3Global provides expert Post Market Surveillance Report (PMSR) services to help medical device manufacturers meet EU MDR requirements and maintain continuous compliance throughout the device lifecycle. Our team supports the development, implementation, and maintenance of PMS reports that systematically collect, analyze, and evaluate real-world device data to ensure ongoing safety, quality, and performance.

We help manufacturers establish effective post-market surveillance systems that support risk management, regulatory readiness, and continuous product improvement.

Book a Free 15-Minute Compliance Call
Get PMSR Support

Expert Post Market Surveillance Report Support for Medical Devices

Post-market surveillance is a regulatory requirement for medical device manufacturers regardless of device classification. Under the EU MDR, manufacturers are required to establish and maintain a post-market surveillance system that is proportionate to the risk class and type of device. The purpose of this system is to proactively collect and analyze information relating to device performance and safety after it has been placed on the market.

A well-structured Post Market Surveillance Report (PMSR) allows manufacturers to continuously monitor real-world performance, reassess benefit-risk profiles, identify emerging safety concerns, and implement corrective or preventive actions when required.

Cert3Global helps manufacturers build practical and compliant PMS systems that align with EU MDR requirements and support long-term regulatory success.

What is a Post Market Surveillance Report (PMSR)?

A Post Market Surveillance Report (PMSR) is a systematic and proactive document that records and evaluates information about the quality, safety, and performance of a medical device throughout its lifecycle.

The report is designed to gather data from multiple sources, including customer complaints, incident reports, scientific literature, user feedback, and post-market clinical information. This data is then analyzed to determine whether the benefit-risk profile of the device remains acceptable and whether corrective actions are necessary.

Under EU MDR, the PMS report forms an essential part of the technical documentation and supports continuous monitoring and improvement of medical devices after market placement.

Why is a Post Market Surveillance Report Important?

A Post Market Surveillance Report plays a critical role in maintaining device safety and regulatory compliance.
Clinical investigations and pre-market evaluations are performed under controlled conditions and on relatively limited populations. Once a device enters the market, it is used by larger and more diverse patient groups. Real-world usage can reveal issues that may not have been identified during pre-market studies.
An effective PMS system helps manufacturers:
  • Monitor device performance throughout its lifecycle
  • Detect emerging risks and adverse trends early
  • Continuously update benefit-risk assessments
  • Support product improvements and corrective actions
  • Demonstrate ongoing compliance with EU MDR requirements
  • Improve patient safety and product quality
The PMS report closes the loop between pre-market evidence and real-world performance by ensuring that manufacturers continuously evaluate and improve their devices based on post-market experience.
Contact Us

Features of an Effective Post Market Surveillance Report

An effective Post Market Surveillance Report is more than a regulatory document. It is a living process that helps manufacturers continuously assess device safety and performance.

Proactive Data Collection

A strong PMS system actively gathers information from multiple sources such as user feedback, complaints, scientific literature, and post-market clinical follow-up activities.

Statistical Analysis and Trend Monitoring

Manufacturers should establish processes to identify statistically significant increases in incident frequency or severity and investigate emerging trends before they become critical issues.

Continuous Benefit-Risk Evaluation

Real-world performance data should be used to verify whether the clinical benefits of the device continue to outweigh its risks.

Integration with Risk Management

New risks identified through PMS activities should be incorporated into the manufacturer’s risk management processes to support continuous improvement.

Corrective and Preventive Actions (CAPA)

The PMS report should document actions taken to address identified issues, including design improvements, labeling changes, process modifications, and field safety corrective actions where necessary.

These elements help manufacturers maintain regulatory readiness while supporting long-term product safety and effectiveness.

How is the Post Market Surveillance Report Connected to ISO 13485?

The Post Market Surveillance Report should be integrated into the manufacturer’s Quality Management System in accordance with ISO 13485 requirements.
PMS activities are closely connected to quality management processes because they provide real-world information regarding device performance, safety, and quality. This information supports management reviews, risk assessments, and continuous improvement initiatives.
An effective PMS process should:
  • Be integrated with the Quality Management System
  • Support preventive and corrective action processes
  • Contribute to continuous risk management activities
  • Provide information for product improvements
  • Help maintain ongoing regulatory compliance
ISO 13485 and EU MDR both emphasize that post-market activities should be proportionate to device risk and should remain active throughout the entire product lifecycle.

Why Choose Cert3Global for Post Market Surveillance Report Services?

Cert3Global provides structured Post Market Surveillance Report services designed to help medical device manufacturers establish effective and compliant PMS systems.
Our support includes:
  • Post Market Surveillance Report preparation and review
  • PMS planning and implementation support
  • Real-world data collection and analysis guidance
  • Benefit-risk evaluation support
  • CAPA integration and documentation assistance
  • ISO 13485 and EU MDR alignment support
  • Ongoing regulatory guidance and lifecycle compliance support
Our team works closely with manufacturers to develop practical PMS strategies that improve regulatory readiness, support patient safety, and maintain long-term compliance.

Build an Effective Post Market Surveillance System!

Post-market surveillance is an essential component of medical device compliance and lifecycle management. A well-developed Post Market Surveillance Report helps manufacturers proactively monitor product performance, identify risks early, and maintain continuous compliance with EU MDR requirements. Partner with Cert3Global to develop a practical, compliant, and effective PMS system that supports both regulatory obligations and product excellence.
Book a Free 15-Minute Compliance Call

FAQs

What is a Post Market Surveillance Report (PMSR)?
A Post Market Surveillance Report is a systematic process used to collect, analyze, and evaluate information relating to the safety, quality, and performance of medical devices after they are placed on the market.
Yes. Under EU MDR, manufacturers are required to establish and maintain a post-market surveillance system and appropriate reporting documentation as part of their technical files.
Post-market surveillance helps manufacturers identify emerging risks, improve device performance, maintain regulatory compliance, and protect patient safety through continuous monitoring.
PMS activities are integrated into the Quality Management System and support risk management, CAPA, management reviews, and continuous improvement processes.
A PMS report typically includes surveillance activities, data sources, trend analysis, benefit-risk evaluations, corrective actions, and conclusions regarding device safety and performance.

Disclaimer

Cert3Global provides regulatory consulting and UK Responsible Person services for cosmetics. Compliance outcomes and market access remain subject to applicable UK cosmetic regulations.